Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
duchenne muscular dystrophy
3
×
eli lilly
3
×
fda
3
×
glaxosmithkline
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
biogen
biotech
bristol-myers squibb
celgene
chinook therapeutics
gene therapy
genentech
incyte
What
bio
3
×
roundup
crispr
days
alliance
august
biopharma
biotech
bristol
busy
buy
calls
changing
color
congress
congressional
decisions
devices
drugs
executives
fda
feud
group
growing
hours
isn’t
known
kudos
later
leaves
legacy
month
myers’s
new
news
nods
notifying
ny
october
opioid
Language
unset
Current search:
glaxosmithkline
×
bio
×
fda
×
" eli lilly "
×
" duchenne muscular dystrophy "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More